An artificial intelligence tool that reads chest X-rays without oversight from a radiologist got regulatory clearance in the European Union last week -- a first for a fully autonomous medical imaging AI, the company, called Oxipit, said in a statement. It's a big milestone for AI and likely to be contentious, as radiologists have spent the last few years pushing back on efforts to fully automate parts of their job. The tool, called ChestLink, scans chest X-rays and automatically sends patient reports on those that it sees as totally healthy, with no abnormalities. Any images that the tool flags as having a potential problem are sent to a radiologist for review. Most X-rays in primary care don't have any problems, so automating the process for those scans could cut down on radiologists' workloads, the Oxipit said in informational materials.

The Final Report also makes specific recommendations for the introduction of legislation which regulates the use of facial recognition and other biometric technology, and for a moratorium on the use of this technology in AI-informed decision-making until such legislation is enacted. The recommendations of the AHRC have been submitted to the Australian Government. The Australian Government has the ability to determine whether to adopt the recommendations of the Report or not. The adoption of the AHRC's recommendations for the introduction of specific legislation governing the use of AI would signal a change in the approach to the regulation of AI and other emerging technologies that has been adopted in Australia to date. Free data access is an issue in the use of AI tools in the provision of legal services in Australia. The success of an AI tool will be determined by the size and diversity of the sample data which is used to train that tool. There are a number of factors that contribute to free data access in Australia and generally these factors apply across the spectrum of different categories of AI tools discussed in question 2 (being litigation, transactional and knowledge management tools).

Epic Games, the developer of the hugely successful video game Fortnite, has revealed it's raised $144 million (£109.5 million) for Ukraine. In conjunction with Microsoft's Xbox, the firm had pledged to donate all of its proceeds from the game to Ukraine relief efforts for two weeks, starting March 20. The total will fund humanitarian relief efforts led by several charities to help Ukrainian people affected by the ongoing war with Russia, Epic Games said. These charities include UNICEF, Direct Relief, the United Nations High Commissioner for Refugees and the World Food Programme. Fornite's Twitter page posted: 'Our deepest thanks to everyone who joined us in supporting humanitarian relief efforts for people affected by the war in Ukraine.

Directed energy is "the ability to create a high amount of energy in a controlled volume at a given distance in order to trigger physical reactions to study the interaction between the energy and the matter," says Dr. Chaouki Kasmi, who is the Chief Researcher at DERC, which is part of the Abu Dhabi government's Advanced Technology Research Council. The research at DERC reflects the multitude of applications that are possible using directed energy, but the research projects have at least one thing in common: the goal of solving real-world scientific or technical challenges. For example, one of DERC's recent developments is a landmine detection system – the ground-penetrating radar - designed to help developing or previously war-torn countries detect and neutralize unexploded landmines. They have their sights set much higher and further with projects focused on using lasers for communications on land, to the moon, and even underwater--truly making the entire world a better place with directed energy technology. "The disruptive innovation that we are bringing today is how we can make it affordable for developing countries. The idea is to create a technology that could really help solve a worldwide problem at low cost. And this is very important for us as we would like to have the system deployed at scale," says Dr. Kasmi.

Saryu Nayyar is CEO of Gurucul, a provider of behavioral security analytics technology and a recognized expert in cyber risk management. The world has entered a new era of cyberthreats, including actual cyber warfare against strategic digital assets. In fact, the Cybersecurity & Infrastructure Security Agency (CISA) is warning organizations to put their "shields up" to protect against cyberattacks. Key industries such as banking, manufacturing and critical infrastructure are especially vulnerable. Security Operations Center (SOC) teams are the tip of the spear for defending the systems and applications that enable their companies to function.

Both houses of the U.S. Congress now have significant legislation designed specifically to rein in AI created by contractors for use by the federal government. The news arrives as an influential non-governmental research institute has issued a major critique of the European Commission's proposed AI Act, citing problems and suggested solutions. A House of Representatives bill would create new rules for how the federal government buys artificial intelligence, presumably including biometric applications. The Senate already is deliberating its version of the legislation. Both bodies have to agree on bills for them to be sent to the president for a signature.

Aigent is seeking a an ambitious and determined Remote Sales Development Representative to join our sales team. Our Artificial Intelligence platform provides real-time, content-based guidance to call center agents, supporting call centers in the financial services, fintech, insurance, insurtech, and healthtech verticals. As an SDR, you will be responsible for identifying and creating new qualified sales opportunities for our sales team. The SDR will be the first point of contact for new business to develop relationships with prospects and work with key stakeholders to develop strategies and tactics in order to create demand to hit targets. This position will be on our US-based team and will report to the Director of Sales.

Don't look now, but using Google Analytics to track your website's audience might be illegal. That's the view of a court in Austria, which in January found that Google's data product was in breach of the European Union's General Data Protection Regulation (GDPR) as it was not doing enough to make sure data transferred from the EU to the company's servers in the US was protected (from, say, US intelligence agencies). Well for those working in AI and biotech, it matters, especially to those working outside of Europe with a view to expansion there. For a start, this is a major precedent that threatens to upend the way many tech companies work, since the tech sector relies heavily on the safe use and transfer of large quantities of data. Whether you use Google Analytics is neither here nor there; the case has shown that Privacy Shield -- the EU-US framework that governs the transfer of personal information in compliance with GDPR -- may not be compliant with European law after all.

Any developer can be a space developer with Azure. Microsoft has a long history of empowering the software development community. We have the world's most comprehensive developer tools and platforms from Github to Visual Studio, and we support a wide range of industries and use cases from healthcare, financial services, critical industries, and now space. As Microsoft expands its focus toward space, we are bringing the power, approachability, and security of our developer story to the next frontier. Microsoft is empowering developers with a platform for on-orbit compute at the ultimate edge, so that spacecraft running AI workloads are connected to the hyperscale Azure cloud.

There is a common misconception that once AI becomes embedded in healthcare processes, it will take away human jobs. That scenario is unlikely to occur, however, because AI's true role is to aggregate and analyze reams of data. That task is difficult for humans, so AI will be a welcome partner in clinical decision-making. This stance is supported by Scott Gottlieb, former commissioner at the Food and Drug Administration (FDA) and now a board member at Pfizer and Illumina. He is also a senior fellow at the American Enterprise Institute, a public policy firm.